171 related articles for article (PubMed ID: 28160853)
1. Identification of acetylshikonin as the novel CYP2J2 inhibitor with anti-cancer activity in HepG2 cells.
Park SH; Phuc NM; Lee J; Wu Z; Kim J; Kim H; Kim ND; Lee T; Song KS; Liu KH
Phytomedicine; 2017 Jan; 24():134-140. PubMed ID: 28160853
[TBL] [Abstract][Full Text] [Related]
2. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
Lu J; Liu D; Zhou X; Chen A; Jiang Z; Ye X; Liu M; Wang X
Phytomedicine; 2018 Jan; 39():137-145. PubMed ID: 29433675
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory potential of Broussochalcone A for the human cytochrome P450 2J2 isoform and its anti-cancer effects via FOXO3 activation.
Park SH; Lee J; Shon JC; Phuc NM; Jee JG; Liu KH
Phytomedicine; 2018 Mar; 42():199-206. PubMed ID: 29655687
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells.
Jeon YJ; Kim JS; Hwang GH; Wu Z; Han HJ; Park SH; Chang W; Kim LK; Lee YM; Liu KH; Lee MY
Eur J Pharmacol; 2015 Oct; 764():480-488. PubMed ID: 26209360
[TBL] [Abstract][Full Text] [Related]
5. Acetylshikonin is a novel non-selective cytochrome P450 inhibitor.
Shon JC; Phuc NM; Kim WC; Heo JK; Wu Z; Lee H; Liu KH
Biopharm Drug Dispos; 2017 Dec; 38(9):553-556. PubMed ID: 28866862
[TBL] [Abstract][Full Text] [Related]
6. Potential of decursin to inhibit the human cytochrome P450 2J2 isoform.
Lee B; Wu Z; Sung SH; Lee T; Song KS; Lee MY; Liu KH
Food Chem Toxicol; 2014 Aug; 70():94-9. PubMed ID: 24788058
[TBL] [Abstract][Full Text] [Related]
7. Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation.
Lim HM; Lee J; Yu SH; Nam MJ; Cha HS; Park K; Yang YH; Jang KY; Park SH
Oxid Med Cell Longev; 2022; 2022():9139338. PubMed ID: 35308176
[TBL] [Abstract][Full Text] [Related]
8. 6,8-Diprenylorobol Induces Apoptosis in Human Hepatocellular Carcinoma Cells via Activation of FOXO3 and Inhibition of CYP2J2.
Lee CM; Lee J; Jang SN; Shon JC; Wu Z; Park K; Liu KH; Park SH
Oxid Med Cell Longev; 2020; 2020():8887251. PubMed ID: 33312341
[TBL] [Abstract][Full Text] [Related]
9. Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes.
Lee E; Kim JH; Shon JC; Wu Z; Kim HJ; Gim M; Lee T; Liu KH
Drug Metab Pharmacokinet; 2018 Jun; 33(3):159-163. PubMed ID: 29759885
[TBL] [Abstract][Full Text] [Related]
10. Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice.
Wang J; Iannarelli R; Pucciarelli S; Laudadio E; Galeazzi R; Giangrossi M; Falconi M; Cui L; Navia AM; Buccioni M; Marucci G; Tomassoni D; Serini L; Sut S; Maggi F; Dall'Acqua S; Marchini C; Amici A
Pharmacol Res; 2020 Nov; 161():105123. PubMed ID: 32822867
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole.
Matsumoto S; Hirama T; Matsubara T; Nagata K; Yamazoe Y
Drug Metab Dispos; 2002 Nov; 30(11):1240-5. PubMed ID: 12386130
[TBL] [Abstract][Full Text] [Related]
12. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Lee CA; Jones JP; Katayama J; Kaspera R; Jiang Y; Freiwald S; Smith E; Walker GS; Totah RA
Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
[TBL] [Abstract][Full Text] [Related]
13. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
14. Acetylshikonin inhibits growth of oral squamous cell carcinoma by inducing apoptosis.
Kim DJ; Lee JH; Park HR; Choi YW
Arch Oral Biol; 2016 Oct; 70():149-157. PubMed ID: 27371806
[TBL] [Abstract][Full Text] [Related]
15. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
Lee E; Wu Z; Shon JC; Liu KH
Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
[TBL] [Abstract][Full Text] [Related]
16. Posttranslational regulation of CYP2J2 by nitric oxide.
Park JW; Lee CM; Cheng JS; Morgan ET
Free Radic Biol Med; 2018 Jun; 121():149-156. PubMed ID: 29715548
[TBL] [Abstract][Full Text] [Related]
17. The in vitro cytotoxic activity of ethno-pharmacological important plants of Darjeeling district of West Bengal against different human cancer cell lines.
Tiwary BK; Bihani S; Kumar A; Chakraborty R; Ghosh R
BMC Complement Altern Med; 2015 Feb; 15():22. PubMed ID: 25887417
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of human small intestinal and liver microsomal astemizole O-demethylation: different contribution of CYP2J2 in the small intestine and liver.
Matsumoto S; Hirama T; Kim HJ; Nagata K; Yamazoe Y
Xenobiotica; 2003 Jun; 33(6):615-23. PubMed ID: 12851038
[TBL] [Abstract][Full Text] [Related]
19. Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB.
Ahmadian E; Eftekhari A; Babaei H; Nayebi AM; Eghbal MA
Anticancer Agents Med Chem; 2017 Nov; 17(11):1570-1577. PubMed ID: 28356024
[TBL] [Abstract][Full Text] [Related]
20. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
Phuc NM; Wu Z; O Y; Lee JH; Oh S; Song GY; Liu KH
Drug Metab Dispos; 2017 Jul; 45(7):765-769. PubMed ID: 28461575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
